| Literature DB >> 30282416 |
Hsien Pin Chang1, Jong Won Hong1, Won Jai Lee1, Young Seok Kim2, Yoon Woo Koh3, Se-Heon Kim3, Dae Hyun Lew1, Tae Suk Roh2.
Abstract
BACKGROUND: Although previous studies have focused on determining prognostic and causative variables associated with fistula-related complications after head and neck reconstructive surgery, only a few studies have addressed preventive measures. Noting that pooled saliva complicates wound healing and precipitates fistula-related complications, we devised a continuous suction system to remove saliva during early postoperative recovery.Entities:
Keywords: Fistula; Infection; Saliva; Suction
Year: 2018 PMID: 30282416 PMCID: PMC6177638 DOI: 10.5999/aps.2018.00094
Source DB: PubMed Journal: Arch Plast Surg ISSN: 2234-6163
Fig. 1.Application of the Hemovac tube
Application of the Hemovac tube in (A) the pharyngeal setting and (B) the oral setting. The eyelet holes of the tube must be placed within the nostril or the mouth for effective suction.
Fig. 2.Tube in the oral setting
The tube was positioned in a U-shape configuration in the oral setting. The base of the U-shaped tube should not be positioned too far back.
Fig. 3.Configuration of the irrigation system
The tube in the oral and/or pharyngeal setting was connected to an evacuator container, which was connected to wall suction via a pouring spout. PVC, polyvinyl chloride.
Fig. 4.Wound care with distilled water irrigation
Irrigation with distilled water in the intensive care unit. Hourly water irrigation was required to prevent sediment from clogging the tube.
Fig. 5.Tube placement in the oropharyngeal area
A radial forearm free flap was used to reconstruct the soft palate, tonsil, and lateral pharyngeal wall defect. Two tubes were placed in the posterior oropharyngeal wall. The tube on the patient’s left was a L-tube (arrowhead), and the tube with holes on the patient’s right was a continuous irrigation tube (arrow). The tube extended to the hypopharynx where the saliva pooled when the patient was lying in the supine position.
Patients’ clinical characteristics (continuous suction group)
| Patient No. | Age (yr) | Sex | Diagnosis and lesion | Pathology | Flap choice | Neck dissection | Cancer stage | Continuous suction setting | Continuous suction maintenance (day) | Previous treatment/recurrence interval | Complication (reason) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 43 | M | Tongue cancer extending to the hypopharynx | SCC | ALT | Bilateral SOND | IV | Oral/pharyngeal | 9 | Leakage/partial N (recipient tongue) | |
| 2 | 62 | F | Tongue cancer extending to the oropharynx and soft palate | SCC | ALT | Unilateral SOND | IV | Oral/pharyngeal | 9 | Neoadjuvant RTx/3 mo | |
| 3 | 54 | M | Tongue cancer involving the mouth floor | SCC | ALT Pec Maj | Unilateral SOND | III | Oral/pharyngeal | 8 | Initial op /16 yr Initial post-op RTx/16 yr | Dehiscence/total N (radionecrotic vessels) |
| 4 | 52 | F | Oral cavity cancer of the buccal area and soft palate | SCC | ALT | Unilateral SOND | II | Oral | 6 | ||
| 5 | 72 | F | Oral cavity cancer of the buccal and retromolar areas | SCC | ALT | None | II | Oral/pharyngeal | 4 | Initial op/8 yr Initial post-op RTx/6 yr | Hematoma (release of tie on branch of external jugular vein) |
| 6 | 59 | M | Oral cavity cancer of the buccal area | SCC | ALT | Unilateral SOND | IV | Oral | 10 | ||
| 7 | 60 | F | Maxillary sinus cancer of the maxilla and orbit | Adeno Ca | ALT | None | IV | Oral | 7 | ||
| 8 | 61 | F | Tongue cancer | Adeno Ca | ALT | Unilateral SOND | II | Oral | 9 | ||
| 9 | 63 | M | Tongue cancer extending to the hypopharynx | SCC | Rectus mc, Pec Maj | Bilateral MRND | IV | Oral/pharyngeal | 17 | Pre-op RTx/30 yr | Dehiscence (radionecrosis of neck flap) |
| 10 | 48 | F | Oral cavity cancer of the buccal area extending to the maxilla and mandible | Pleom | Fibular oc | Unilateral MRND | IV | Oral | 13 | Initial op/10 mo, Initial post-op RTx/10 mo | |
| 11 | 48 | M | Tongue cancer involving the mouth floor | SCC | ALT | Unilateral SOND | II | Oral | 7 | ||
| 12 | 81 | F | Oral cavity cancer of the mouth floor | SCC | ALT | Unilateral SOND | III | Oral | 1 | ||
| 13 | 65 | F | Oral cavity cancer of the mouth floor | Adeno Ca | ALT | None | III | Oral | 3 | Op/3 yr | |
| 14 | 69 | M | Hypopharyngeal cancer extending to the base of tongue and oropharynx | SCC | ALT | Unilateral SOND | IV | Oral/pharyngeal | 7 | Fistula (POD 14) | |
| 15 | 52 | M | Oropharyngeal cancer of the soft palate and tonsil | SCC | ALT | None | IV | Oral/pharyngeal | 8 | ||
| 16 | 79 | M | Tongue cancer extending to the larynx | SCC | Rectus mc | Unilateral MRND | IV | Oral/pharyngeal | 7 | Pre-op RTx/22 yr | |
| 17 | 28 | F | Oral cavity cancer of the buccal area, retromolar area, and lower lip | SCC | ALT | Unilateral SOND | IV | Oral | 7 | Initial op/3 yr, Initial post- op RTx/7 mo | |
| 18 | 48 | M | Tongue cancer involving the mouth floor | SCC | ALT | Unilateral MRND | II | Oral | 5 | ||
| 19 | 53 | M | Hypopharyngeal cancer extending to the base of the tongue and oropharynx | SCC | ALT | Unilateral SOND | IV | Oral/pharyngeal | 6 | Partial N (venous insufficiency/flap congestion) | |
| 20 | 62 | M | Hypopharyngeal cancer extending to the base of the tongue and oropharynx | SCC | ALT | Bilateral MRND | IV | Oral/pharyngeal | 7 |
M, male; SCC, squamous cell carcinoma; ALT, anterolateral thigh flap; SOND, supraomohyoid neck dissection; N, necrosis; F, female; RTx, radiotherapy; Pec Maj, pectoralis major myocutaneous flap; op, operation; Adeno Ca, adenocarcinoma; Rectus mc, rectus musculocutaneous flap; Pleom, pleomorphic carcinoma; Fibular oc, fibular osteocutaneous flap; MRND, modified radical neck dissection; POD, postoperative day.
Comparison of baseline patient characteristics
| Variable | Suction device group (n = 20) | Non-suction device group (n = 16) | P-value |
|---|---|---|---|
| Age (yr) | 57.95 ± 12.45 | 58.56 ± 13.58 | 0.890 |
| Sex | 0.400 | ||
| Male | 11/20 (55) | 9/16 (45) | |
| Female | 11/20 (68.8) | 5/16 (31.3) | |
| Pathology | 0.613 | ||
| SCC | 16/20 (80) | 15/16 (93.8) | |
| Adeno ca. | 3/20 (15) | 1/16 (6.3) | |
| Pleom | 1/20 (5) | 0/16 (0) | |
| Type of flap | 0.204 | ||
| ALT | 17/20 (85) | 11/16 (68.8) | |
| Rectus mc | 2/20 (10) | 5/16 (31.3) | |
| Fibular oc | 1/20 (5) | 0/16 (0) | |
| Neck dissection | |||
| Performed | 17/20 (85) | 16/16 (100) | |
| Not performed | 3/20 (15) | 0/16 (0) | |
| Cancer stage | 0.353 | ||
| II | 5/20 (25) | 1/16 (6.3) | |
| III | 2/20 (10) | 3/16 (18.8) | |
| IV | 13/20 (65) | 12/16 (75) | |
| Preoperative radiotherapy | 0.722 | ||
| Performed | 5/20 (25) | 5/16 (31.3) | |
| Not performed | 15/20 (75) | 11/16 (68.8) | |
| Underlying disease | |||
| Hypertension | 8/20 (40) | 8/16 (50) | 0.549 |
| Smoking history | 10/20 (50) | 9/20 (56.3) | 0.709 |
| Diabetes mellitus | 3/20 (15) | 4/16 (25) | 0.675 |
| Previous head and neck cancer | 8/20 (40) | 2/16 (12.5) | 0.133 |
Values are presented as mean±SD or number/number (%).
SCC, squamous cell carcinoma; Adeno ca, adenocarcinoma; Pleom, pleomorphic carcinoma; ALT, anterolateral thigh flap; Rectus mc, rectus musculocutaneous flap; Fibular oc, fibular osteocutaneous flap.
Comparison of length of hospitalization, ICU stay, HV drainage, and amylase levels
| Variable | Suction device group (n = 20) | Non-suction device group (n = 16) | P-value |
|---|---|---|---|
| Length of stay (day) | 0.010 | ||
| Mean ± SD | 26.25 ± 15.71 | 43.75 ± 22.97 | |
| Range | 13–78 | 18–90 | |
| Length of ICU stay (day) | 0.281 | ||
| Mean ± SD | 3.35 ± 0.99 | 5.13 ± 7.19 | |
| Range | 2–5 | 1–31 | |
| Maintenance of continuous suction (day) | |||
| Mean ± SD | 7.50 ± 3.41 | NA | |
| Range | 1–17 | NA | |
| HV drainage below 10 mL (day) | 0.011 | ||
| Mean ± SD | 6.50 ± 2.80 | 8.73 ± 1.75 | |
| Range | 3–13 | 6–12 | |
| Amylase level on day 3 (U/L) | 0.734 | ||
| Mean ± SD | 1,315.50 ± 2,177.09 | 1,685.40 ± 2,605.75 | |
| Range | 15–7,677 | 40–7,201 |
ICU, intensive care unit; HV, Hemovac; SD, standard deviation; NA, not available.
Complications after reconstructive surgery
| Events | Incidence | P-value | |
|---|---|---|---|
| Suction device group (n = 20) | Non-suction device group (n = 16) | ||
| Fistula/leakage | 2 (10) | 1 (6.3) | 1.0 |
| Infection | 0 | 4 (25) | 0.031 |
| Hematoma/bleeding | 1 (5) | 2 (12.5) | 0.574 |
| Wound dehiscence | 2 (10) | 2 (12.5) | 1.0 |
| Flap necrosis (partial/total) | 2 (10) | 2 (12.5) | 1.0 |
Values are presented as number (%).